Search Result "why EA."
NO to Breast: When, Why and Why Not?
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 4 Year: 2010 Page: 451-462
Author(s): Shehla Pervin, Gautam Chaudhuri, Rajan Singh
Predicting Drug-Likeness: Why and How ?
Journal: Current Topics in Medicinal Chemistry
Volume: 2 Issue: 1 Year: 2002 Page: 1273-1286
Author(s): Ajay
Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?
Journal: Current Cardiology Reviews
Volume: 2 Issue: 4 Year: 2006 Page: 293-316
Author(s): Isabelle Pham, Alain Nitenberg
Why is the Incidence of Type 1 Diabetes Increasing?
Journal: Current Diabetes Reviews
Volume: 17 Issue: 8 Year: 2021 Page: 3-15
Author(s): Alexia G. Abela,Stephen Fava
The Use of Metabolising Systems for In Vitro Testing of Endocrine Disruptors
Journal: Current Drug Metabolism
Volume: 9 Issue: 8 Year: 2008 Page: 796-826
Author(s): M. N. Jacobs, W. Janssens, U. Bernauer, E. Brandon, S. Coecke, R. Combes, P. Edwards, A. Freidig, A. Freyberger, R. Kolanczyk, C. Mc Ardle, O. Mekenyan, P. Schmieder, T. Schrader, M. Takeyoshi, B. van der Burg
Why have SGLT2 Inhibitors Failed to Achieve the Desired Success inCOVID-19?
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 15 Year: 2024 Page: 1149-1156
Author(s):
Why Is Homocysteine Toxic for the Nervous and Immune Systems?
Journal: Current Aging Science
Volume: 6 Issue: 1 Year: 2013 Page: 29-36
Author(s): Alexander Boldyrev, Ekaterina Bryushkova, Anna Mashkina, Elizaveta Vladychenskaya
The Role of Saliva Cortisol Measurement in Health and Disease. Introduction - Why This Book?
Ebook: The Role of Saliva Cortisol Measurement in Health and Disease
Volume: 1 Year: 2012
Author(s): Margareta Kristenson,Peter Garvin,Ulf Lundberg
Doi: 10.2174/978160805342111201010003
Why So Few Drugs for Alzheimers Disease? Are Methods Failing Drugs?
Journal: Current Alzheimer Research
Volume: 7 Issue: 7 Year: 2010 Page: 642-651
Author(s): R. E. Becker, N. H. Greig
The Genetic Basis of Kidney Cancer: Why is Tuberous Sclerosis Complex Often Overlooked?
Journal: Current Molecular Medicine
Volume: 4 Issue: 8 Year: 2004 Page: 825-831
Author(s): Elizabeth Petri Henske